Lindsay A. Sobotka

ORCID: 0000-0003-1052-2067
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Organ Transplantation Techniques and Outcomes
  • Hepatitis Viruses Studies and Epidemiology
  • Hepatitis C virus research
  • Cystic Fibrosis Research Advances
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Multiple and Secondary Primary Cancers
  • Economic and Financial Impacts of Cancer
  • Abdominal vascular conditions and treatments
  • Acute Myeloid Leukemia Research
  • Inflammatory Bowel Disease
  • Long-Term Effects of COVID-19
  • Hepatitis B Virus Studies
  • Renal Transplantation Outcomes and Treatments
  • Pregnancy and Medication Impact
  • Enhanced Recovery After Surgery
  • Hemoglobinopathies and Related Disorders
  • Esophageal and GI Pathology
  • Pancreatic and Hepatic Oncology Research
  • Folate and B Vitamins Research
  • Healthcare Policy and Management
  • Neonatal Respiratory Health Research

The Ohio State University
2017-2024

The Ohio State University Wexner Medical Center
2016-2024

Janssen (Belgium)
2021

Pfizer (United States)
2021

Creative Research Enterprises (United States)
2017-2018

Ocní klinika
2010

Background & aims Previous studies have examined the effects of metabolic syndrome (MetS) rather than its severity on race and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). We used MetS score, a validated sex-race-ethnicity-specific measure, to examine race/ethnicity association between MASLD. Methods This study included 10,605 adult participants from Third National Health Nutrition Examination Survey. The MASLD diagnosis was based ultrasound...

10.1371/journal.pone.0299836 article EN cc-by PLoS ONE 2024-03-15

INTRODUCTION: Acute pancreatitis (AP) occurs among patients with pancreas-sufficient cystic fibrosis (PS-CF) but is reportedly less common pancreas-insufficient (PI-CF). The incidence of AP may be influenced by transmembrane conductance regulator (CFTR) modulator use. We hypothesized that CFTR modulators would reduce hospitalizations, the greatest benefit in PS-CF. Methods: MarketScan (2012–2018) was queried for hospitalizations and use CF. Multivariable Poisson models enabled crossover...

10.14309/ajg.0000000000001527 article EN The American Journal of Gastroenterology 2021-10-19

ABSTRACT Despite advances in treatment for cystic fibrosis (CF), liver disease remains a major contributor to morbidity and mortality persons with CF. Therefore, transplantation may be considered end-stage CF-related disease. We present young patient CF who underwent solo has successfully restarted on elexacaftor/tezacaftor/ivacaftor without significant pulmonary or hepatic complications after transplant.

10.14309/crj.0000000000001261 article EN cc-by-nc-nd ACG Case Reports Journal 2024-01-01

Previous studies have identified treatment disparities in the of hepatocellular carcinoma (HCC) based on insurance status and provider. Recent shown more Americans healthcare insurance; therefore we aim to determine if providers continue exist. A retrospective database analysis using NIS was performed between 2010 2013 including adult patients with a primary diagnosis HCC determined by ICD-9 codes. Multivariable logistic regressions were analyze differences treatment, mortality, features...

10.1016/j.aohep.2018.10.001 article EN cc-by-nc-nd Annals of Hepatology 2019-04-30

The success of direct-acting antivirals (DAA) has transformed the management hepatitis C virus (HCV) infection and led to expansion deceased donor organ pool for liver transplantation.We present a single center retrospective review transplantations performed on HCV-seronegative recipients from HCV-seropositive organs 11/2017 05/2020. HCV nucleic acid testing (NAT) was donors assess active infection.42 underwent transplant donor, including 21 NAT negative (20 liver, 1 simultaneous kidney...

10.1016/j.aohep.2021.100318 article EN cc-by-nc-nd Annals of Hepatology 2021-01-27

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators significantly improve pulmonary function in patients with cystic (CF) but the effect on hepatobiliary outcomes remains unknown. We hypothesized that CF CFTR would have a decreased incidence of cirrhosis compared to not or ursodiol.To investigate development CF.A retrospective analysis was performed using Truven MarketScan from January 2012 through December 2017 including all diagnosis CF. Patients were excluded if they...

10.4254/wjh.v14.i2.411 article EN World Journal of Hepatology 2022-02-21

The Center for Medicare and Medicaid Services established 30-day readmission rate as a key metric in measuring high-value, cost-conscious care; therefore, our aim is to develop risk score ulcerative colitis (UC) patients undergoing colectomy or proctectomy.This study used data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) participant user file (2011-2015). Patients with UC proctectomy were identified using ICD-9, 10, CPT codes. Stepwise...

10.1038/s41424-018-0039-y article EN cc-by-nc-nd Clinical and Translational Gastroenterology 2018-08-01

To determine if racial disparities continue to exist in the treatment of hepatocellular carcinoma (HCC).A retrospective database analysis using Nationwide Inpatient Sample was performed including patients with a primary diagnosis HCC. Univariate and multivariate analyses were utilized liver decompensation, treatment, inpatient mortality, metastatic disease.A total 62604 HCC included consisting 32428 Caucasian, 9726 African-American, 8988 Hispanic, 11462 other races. Caucasian more likely...

10.4254/wjh.v10.i11.849 article EN World Journal of Hepatology 2018-11-27

Abstract Background There is limited literature describing the real‐world practice of delayed initiation and shortened duration direct‐acting antiviral (DAA) in kidney transplant recipients. We compared Hepatitis C virus (HCV) cure rates among recipients who received an HCV nucleic acid test positive (NAT +) were treated with sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks or glecaprevir/pibrentasvir (G/P) 8 weeks, a that 4 shorter than guideline recommendation treatment delay beyond 1‐week...

10.1111/tid.14366 article EN cc-by-nc-nd Transplant Infectious Disease 2024-09-03

To evaluate disparities in the treatment of hepatocellular carcinoma (HCC) based on gender.A retrospective database analysis using Nationwide Inpatient Sample (NIS) was performed between 2010 and 2013. Adult patients with a primary diagnosis determined by International Classification Disease 9 (ICD-9) codes were included. Univariate multivariate logistic regressions to analyze differences treatment, mortality, features decompensation, metastatic disease patient's gender.The included 62582...

10.4254/wjh.v9.i36.1346 article EN World Journal of Hepatology 2017-12-27

AIMTo determine the readmission rate, its reasons, predictors, and cost of 30-d in patients with cirrhosis ascites. METHODSA retrospective analysis nationwide database (NRD) was performed during calendar year 2013.All adults cirrhotics a diagnosis ascites,

10.4254/wjh.v10.i6.425 article EN World Journal of Hepatology 2018-06-27

Abstract Background and Aim Cirrhosis‐related complications are associated with high inpatient mortality, cost, length of stay. There is a lack multi‐centered studies on interventions for hepatic hydrothorax its impact patient outcomes. The aim this study was to determine the effect performing thoracentesis hospital stay, 30‐day readmission. Methods A retrospective analysis Nationwide Inpatient Sample between 2002 2013 Readmission Database during performed including patients primary...

10.1111/jgh.14842 article EN Journal of Gastroenterology and Hepatology 2019-08-23

OBJECTIVES: Performing a sigmoidoscopy or colonoscopy is recommended for assessment of disease activity, excluding infection, and guiding medical treatment during ulcerative colitis (UC)-related hospitalizations. However, it unknown whether the timing endoscopy impacts clinical outcomes. The objective our study was to determine impact on hospital outcomes in patients with UC-related METHODS: This cross-sectional using data from Nationwide Inpatient Sample database (2006–2013). Adult...

10.1038/ctg.2016.61 article EN cc-by-nc-nd Clinical and Translational Gastroenterology 2016-12-01

Psychosocial stressors related to the coronavirus-19 (COVID-19) pandemic increased alcohol consumption. The effect on patients with alcohol-related liver diseases remains unclear.Hospitalizations at a tertiary care center due disease from March 1 through August 31 in 2019 (pre-pandemic cohort) and 2020 (pandemic were reviewed retrospectively. Differences patient demographics, features, outcomes estimated alcoholic hepatitis utilizing T-tests, Mann-Whitney tests, Chi-square Fisher Exact Tests...

10.1016/j.aohep.2023.101088 article EN cc-by-nc-nd Annals of Hepatology 2023-03-16

Given the increased rates of pregnancy in liver transplant recipients, evaluating safety is crucial. We aim to evaluate pregnancy-related complications and outcomes recipients.A retrospective nationwide review comparing recipients vs general population was performed between 2005 2013. Propensity-matched multivariable regression analyses were study pregnancy- delivery-related addition patient hospital outcomes.A total 38,449,030 admissions evaluated this including 1,469 (0.004%) recipients....

10.14309/ajg.0000000000001135 article EN The American Journal of Gastroenterology 2021-01-20

The coronavirus disease 2019 pandemic led to changes in individuals' behaviors and healthcare delivery. We examined the impact of these on rates clinical course acute pancreatitis (AP).Hospitalizations for AP from March 1 through August 31 (baseline group) same period 2020 (pandemic were retrospectively reviewed. Univariate multivariate analyses used demographics outcomes.Two hundred eighty subjects (315 admissions) identified 237 (264 2020. Subjects group more likely have systemic...

10.1097/mpa.0000000000002046 article EN Pancreas 2022-05-01

We sought to evaluate hospital outcomes of cirrhosis patients with nonvariceal upper gastrointestinal bleeding (NVUGIB).NVUGIB is common in cirrhosis. However, national outcome studies these are lacking.We utilized the 2014 Nationwide Readmission Database NVUGIB cirrhosis, further stratified as no (NC), compensated (CC), or decompensated (DC). Validated International Classification Diseases, Ninth Revision, Clinical Modification codes captured diagnoses and interventions. Outcomes included...

10.1097/mcg.0000000000001746 article EN Journal of Clinical Gastroenterology 2022-08-12

Liver involvement by acute leukaemia is rare and has a high mortality rate despite treatment. We report case of 66-year-old woman undergoing treatment for myelodysplastic syndrome with Vidaza (azacitidine) who presented abnormal liver function tests. Despite negative serologic testing unremarkable abdominal MRI, she continued to have significant elevation in bilirubin international normalised ratio worsening mental status. biopsy was obtained consistent myelogenous leukaemia. The patient had...

10.1136/bcr-2018-224590 article EN BMJ Case Reports 2018-06-28

Accurate detection of gastric antral vascular ectasia (GAVE) is critical for proper management cirrhosis-related gastrointestinal bleeding. However, endoscopic diagnosis GAVE can be challenging when overlaps with severe portal hypertensive gastropathy (PHG).To determine the added diagnostic value virtual chromoendoscopy to high definition white light real-time and PHG.We developed an I-scan criteria PHG. We tested our in a cross-sectional cohort cirrhotic adults PHG high-definition endoscopy...

10.4254/wjh.v13.i12.2168 article EN World Journal of Hepatology 2021-12-27

Significant elevations in alpha-fetoprotein should raise suspicion for hepatocellular carcinoma as malignancies with metastasis to the liver can elevate level but typically <300 ng/mL. Diagnosis be confirmed typical characteristics of on imaging and or biopsy confirm diagnosis.

10.1002/ccr3.1956 article EN cc-by Clinical Case Reports 2018-12-16
Coming Soon ...